DIT Announces New Executive Team to Pursue National Platform for Vascular Access

Dallas, Texas, July 28, 2021 / PRNewswire / – Dynamic Infusion Therapy, LLC (“DIT”), a longtime provider of outsourced vascular access services, is pleased to announce a new leadership team that has been put together to grow its platform. With a clinical model aimed at lowering customer costs and leading to better patient outcomes, DIT is the nation’s largest outsourced vascular access insertion provider and has consistently achieved an overall success rate of greater than 99%. Earlier this year RiverGlade Capital, a healthcare focused private equity firm, partnered with DIT to build its reputation for clinical excellence.

Peter Harris, recently named President & Chief Executive Officer, stated, “Our nurses successfully and comfortably introduce vascular access devices to approximately 100,000 patients per year, and we are carefully monitoring quality metrics to drive clinical excellence. Our new leadership team plans to expand the use of these services to support high quality patient care in hospitals, long-term care facilities and many other locations across the country. “

Previously, Mr. Harris held executive positions at a dozen private equity backed companies, serving clients across the country and around the world. He has worked for an interpreting service that offers more than 200 languages ​​to serve leading health organizations, the largest nationwide adult medical provider, hospital company, and the largest US hospice care organization. He has a BA of Northwestern University and a JD from Harvard Law School.

The recently appointed Chief Development Officer of DIT, Tim Boes, is responsible for the company’s growth and acquisitions. “We believe we offer a compelling opportunity at DIT and look forward to expanding our model and services to growing numbers of patients and healthcare organizations,” said Boes, who has over twenty years of healthcare leadership experience in senior positions. has national health care, nursing staff and medical care organizations. Mr. Boes holds a BA in Healthcare Administration from Ithaca College.

Thomas Bumpass, Chief Financial Officer, brings a combination of public accounting experience and 10 years working with private equity backed healthcare IT companies. His experience includes financial roles at an industry leading provider of strategic sourcing, contract lifecycle management and provider management solutions. The scope of his leadership included several acquisitions and the successful sale of a company. Mr. Bumpass holds a BBA in Accounting and a Master of Accounting from Abilene Christian University.

These three new leaders join the company’s Chief Operating Officer, Carla Dillardwho oversees the clinical and operational components of the services provided by DIT. As the company’s longest-serving employee, Carla started working as a nurse at DIT in 2005 shortly after it was founded and brings a wealth of institutional knowledge and experience to her role. Before joining DIT, Carla worked as a registered nurse in acute emergency and intensive care units. Carla received her MSN and BSN from the University of Texas at Arlington College of Nursing, your ADN from Collin Community College of Nursing and is Board Certified in Vascular Access (VABC) by the Vascular Access Certification Corporation.

About DIT
Dynamic Infusion Therapy, founded in 2004 and headquartered in Dallas, TX, is a full-service, outsourced, vascular access provider with a proven clinical model that reduces costs for its customers and leads to better patient outcomes. More information is available at www.dynamicinfusion.com

About RiverGlade Capital
RiverGlade Capital is a private equity firm focused on control buyouts of high-growth, lower-middle-class healthcare companies. RiverGlade works with founder-owned, high quality, differentiated companies that have shown strong organic growth and where value can be accelerated through investment in human capital, operational improvements, strategic planning, and dynamic organic and inorganic growth initiatives. More information is available at http://www.rivergladecapital.com.

SOURCE Dynamic Infusion Therapy, LLC

[ad_1]